| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $634.2M | +20.0% |
| Cost of Revenue | $72.9M | +37.8% |
| Gross Profit | $561.3M | +18.1% |
| R&D Expense | $135.8M | +24.2% |
| SG&A Expense | $383.5M | +18.6% |
| Operating Income | $32.8M | +31.8% |
| Pre-tax Income | $191K | +100.7% |
| Income Tax | $27.3M | -0.2% |
| Net Income | -$27.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $214.0M | +0.1% |
| Short-term Investments | $79.5M | +119.7% |
| Accounts Receivable | $115.3M | +14.1% |
| Inventory | $228.8M | +92.6% |
| Current Assets | $676.2M | +34.0% |
| Total Assets | $949.9M | +21.0% |
| Current Liabilities | $237.8M | +59.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $33.1M | +197.8% |
| Capital Expenditures | $3.3M | -7.2% |
| Investing Cash Flow | -$46.4M | -8191.4% |
| Financing Cash Flow | $610K | -88.1% |
| Free Cash Flow | $29.8M | +179.7% |
| +51.7% |
| EPS (Basic) | -$0.09 | +50.0% |
| EPS (Diluted) | -$0.09 | +50.0% |
| Long-term Debt |
| $392.7M |
| +0.7% |
| Total Liabilities | $675.6M | +14.3% |
| Stockholders' Equity | $274.2M | +41.3% |